Program

Updates in Heart Failure 2026

14-15 December 2026

Stockholm Waterfront Congress Centre, Sweden

Chair: Professor Gianluigi Savarese
Karolinska Institutet & South General Hospital, Stockholm, Sweden

DAY 1 – 14 December 2026

12.00-13.00

Lunch

13.00-13.05 

  • 13.00-13.05 | Welcome and Introduction
    Speaker: TBC
Session 1: The New Heart Failure Guidelines: What Has Changed and What Will Change My Practice?

Speaker: TBC

13:05–13:25

  • 13.05-13.20 | Lecture
    Speaker: TBC
  • 13.20-13.25 | Discussion
    Speaker: TBC
Session 2: HFrEF in 2026: Beyond the Four Pillars?

Chairs: TBC

Discussant: TBC

13:25–14:40

  • 13:25–13:30 | Clinical Case
    Speaker: TBC
  • 13:30–13:40 | Four Pillars in Real-World Practice
    Speaker: TBC
  • 13:40–13:50 | Digitoxin after DIGIT-HF
    Speaker: TBC
  • 13:50–14:00 | Vericiguat after VICTOR
    Speaker: TBC
  • 14:00–14:10 | HFimpEF: Recovery or Remission?
    Speaker: TBC
  • 14:10–14:40 | Expert Exchange
    Speaker: TBC
Session 3: Cardiorenal Syndrome 2026 

Chairs: TBC

Discussant: TBC

14:40–15:55

  • 14:40–14:45 | Clinical Case
    Speaker: TBC
  • 14:45–14:55 | Beyond eGFR
    Speaker: TBC
  • 14:55–15:05 | CKD in Heart Failure
    Speaker: TBC
  • 15:05–15:15 | Hyperkalaemia
    Speaker: TBC
  • 15:15–15:25 | Potassium Binders
    Speaker: TBC
  • 15:25–15:55 | Discussion
    Speaker: TBC

15:55–16:20

Coffee Break
Session 4: HFpEF in 2026: One Syndrome, Many Phenotypes 

Chairs: TBC

Discussant: TBC

16:20–17:35

  • 16:20–16:25 | Clinical Case
    Speaker: TBC
  • 16:25–16:35 | Finding HFpEF Earlier
    Speaker: TBC
  • 16:35–16:45 | Foundational Therapy in HFpEF
    Speaker: TBC
  • 16:45–16:55 | Obesity-Related HFpEF
    Speaker: TBC
  • 16:55–17:05 | AF-Dominant HFpEF
    Speaker: TBC
  • 17:05–17:15 | HFpEF and Pulmonary Hypertension
    Speaker: TBC
  • 17:15–17:35 | Debate
    Speaker: TBC
Session 5: Emerging Therapies and Innovations in Heart Failure 

Chairs: TBC

Discussant: TBC

17:35–18:25

  • 17:35–17:45 | RNA and Gene Editing Therapies
    Speaker: TBC
  • 17:45–17:55 | Inflammation and Fibrosis
    Speaker: TBC
  • 17:55–18:05 | Artificial Intelligence in Heart Failure
    Speaker: TBC
  • 18:05–18:25 | Discussion
    Speaker: TBC
  • 18:25–18:30 | Wrap-Up
  • 18:30–19:15 | Networking & Mingle Reception

DAY 2 – 15 December 2026

  • 08:30–08:35 | Welcome
    Speaker: TBC
  • 08:35–08:55 | State-of-the-Art Lecture
    Iron Deficiency in Heart Failure: From HFrEF to HFpEF—What Comes Next?
    Speaker: TBC
Session 6: Residual Risk in Heart Failure

08:55–10:20

Chairs: TBC

Discussants: TBC

  • 08:55–09:00 | Clinical Case
    Speaker: TBC
  • 09:00–09:10 | ICD Therapy in 2026
    Speaker: TBC
  • 09:10–09:20 | CRT and Conduction System Pacing
    Speaker: TBC
  • 09:20–09:30 | Congestion in 2026: Assessment, Diuretics and Beyond
    Speaker: TBC
  • 09:30–09:40 | Advanced HF: Referral Timing
    Speaker: TBC
  • 09:40–09:50 | Advanced HF: LVAD and Transplant
    Speaker: TBC
  • 09:50–10:20 | Discussion
    Speaker: TBC

10:20–10:45

Coffee Break
Session 7: Valvular Heart Disease in Heart Failure

10:45–12:00

Chairs: TBC

Discussants: TBC

  • 10:45–10:50 | Clinical Case
    Speaker: TBC
  • 10:50–11:00 | Mitral Regurgitation in HF
    Speaker: TBC
  • 11:00–11:10 | Tricuspid Regurgitation in HF
    Speaker: TBC
  • 11:10–11:20 | Aortic Stenosis and HF
    Speaker: TBC
  • 11:20–11:30 | Heart Team Approach
    Speaker: TBC
  • 11:30–12:00 | Discussion
    Speaker: TBC

12:00–13:00

Lunch
Session 8: Cardiomyopathies in 2026

13:00–14:15

Chairs: TBC

Discussants: TBC

  • 13:00–13:05 | Clinical Case
    Speaker: TBC
  • 13:05–13:15 | Cardiac Amyloidosis
    Speaker: TBC
  • 13:15–13:25 | ATTR-CM Therapies
    Speaker: TBC
  • 13:25–13:35 | Hypertrophic Cardiomyopathy
    Speaker: TBC
  • 13:35–13:45 | Diagnostic Pathways
    Speaker: TBC
  • 13:45–14:15 | Discussion
    Speaker: TBC
Session 9: Delivering Better Heart Failure Care in 2026

14:15–15:05

Chairs: TBC

Discussants: TBC

  • 14:15–14:25 | Telemonitoring and Remote Management
    Speaker: TBC
  • 14:25–14:35 | Polypharmacy, Adherence and Persistence
    Speaker: TBC
  • 14:35–14:45 | Multidisciplinary HF Care and Transitions of Care
    Speaker: TBC
  • 14:45–15:05 | Expert Panel Discussion
    Speaker: TBC
  • 15:05–15:10 | Closing Remarks

Scroll to Top